Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Menu
Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Investors
Financials and Filings
Financials and Filings
Select Year
2022
2021
05.31.2022
Interim Consolidated Financial Statements for the three months ended March 31, 2022
05.31.2022
Management’s Discussion and Analysis for the three months ended March 31, 2022
04.28.2022
Consolidated Financial Statements for December 31, 2021
04.28.2022
Management’s Discussion and Analysis for the year ended December 31, 2021
04.29.2021
2020 Audited Statements
Investors
Quick Links
Stock Info
News
2023
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
View Video
Read More
Latest News
View All
View All
TSX-V: ACI
15 min delay
Last
$9.75
Change
$0.03
Open
9.77
Vol
1294936
High
10.05
Low
9.69
Stock Information
